Daxor Corporation's BVA-100 Blood Volume Diagnostic Expands To Three New Centers, Gains Traction Nationwide
Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration
Oak Ridge, TN, July 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA). This growth includes launching a BVA program and increasing adoption of Daxor's ezBVA Lab service - a state-of-the-art CLIA certified facility that provides on-demand, next day blood volume analysis results. The company foresees a strong lineup of developments in the second half of this year, reinforcing its trajectory of accelerated sales growth.
Recent sales wins include:
- Regional referral center for Northeast Arkansas and Southeast Missouri starts a BVA program.
- Covenant Health affiliate, a 300-bed facility, integrates Daxor's ezBVA Lab service.
- Leading South Texas teaching hospital and Level 1 trauma center adopts Daxor's ezBVA Lab service.